← Back to Search

N/A

Cheese Consumption for Inflammation

N/A

Waitlist Available

Led By Jennifer T. Smilowitz, PhD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-65 years

Two or more components of metabolic syndrome: Central obesity, fasting blood triglycerides, plasma HDL cholesterol, blood pressure, fasting glucose, or BMI equal to or greater than 30

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0, 1, 3, 6 hr postprandial

Awards & highlights

Study Summary

This trial is testing whether cheese or a cheese substitute impacts inflammation over six hours.

Who is the study for?

This trial is for adults aged 18-65 with metabolic syndrome, characterized by conditions like central obesity or high blood pressure. Participants should not have eating disorders, immune diseases, severe allergies to study foods, diabetes, recent changes in exercise or diet habits, a BMI over 40 or weight over 400 lbs., and must not be planning pregnancy.Check my eligibility

What is being tested?

The study compares the effects of consuming cheddar cheese versus vegan cheese on inflammation in individuals with metabolic syndrome. Over six hours, researchers will monitor how these two types of cheese influence inflammatory responses.See study design

What are the potential side effects?

Potential side effects are not specified but may include digestive discomfort due to lactose intolerance for those sensitive to dairy products. Vegan cheese could also cause issues if participants have unknown allergies to its components.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I have at least two symptoms of metabolic syndrome.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0, 1, 3, 6 hr postprandial

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0, 1, 3, 6 hr postprandial

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 1, 3, 6 hr postprandial for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Inflammation

Secondary outcome measures

Plasma bone markers

Plasma glucose

Plasma lipid profile

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CheeseExperimental Treatment1 Intervention

Cheese sandwich plus supplemental beverage will deliver 40% of each participants' energy expenditure and will be made up of 50% of energy as fat, 35% of energy as carbohydrate and 15% of energy as protein. The sandwich will contain medium cheddar cheese and whole wheat bread. The supplemental beverage will contain fruit sorbet, glucose polymer, protein powder, high oleic sunflower oil, high polyunsaturated fatty acids (PUFA) sunflower oil, and canola oil.

Group II: Vegan cheeseActive Control1 Intervention

Non-dairy cheese alternative sandwich plus supplemental beverage will deliver 40% of each participants' energy expenditure and will be made up of 50% of energy as fat, 35% of energy as carbohydrate and 15% of energy as protein. The sandwich will contain vegan cheese and whole wheat bread. The supplemental beverage will contain fruit sorbet, glucose polymer, protein powder, cream of tartar, high oleic sunflower oil, high PUFA sunflower oil, and palm oil.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dairy Research InstituteOTHER

17 Previous Clinical Trials

991 Total Patients Enrolled

4 Trials studying Metabolic Syndrome

270 Patients Enrolled for Metabolic Syndrome

University of California, DavisLead Sponsor

910 Previous Clinical Trials

4,706,971 Total Patients Enrolled

12 Trials studying Metabolic Syndrome

652 Patients Enrolled for Metabolic Syndrome

Jennifer T. Smilowitz, PhDPrincipal InvestigatorUniversity of California, Davis

1 Previous Clinical Trials

395 Total Patients Enrolled

Media Library

Cheddar cheese (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT01803633 — N/A

Metabolic Syndrome Research Study Groups: Vegan cheese, Cheese

Metabolic Syndrome Clinical Trial 2023: Cheddar cheese Highlights & Side Effects. Trial Name: NCT01803633 — N/A

Cheddar cheese (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01803633 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this experiment still open?

"Unfortunately, as reported on clinicaltrials.gov, this medical trial is no longer actively recruiting participants; the posting was initially made on September 1st 2012 and updated for the last time almost a decade later in 2022. However, at present there are 1392 other trials that are still open to enrolling new candidates."

Answered by AI

Does the eligibility criteria for this clinical experiment include people below 55 years of age?

"As indicated by the conditions of enrolment, only those aged 18 or over and 65 or below may be included in this medical experiment."

Answered by AI

What are the eligibility requirements for participating in this medical experiment?

"This study is in search of 20 individuals, aged 18-65, who have been diagnosed with metabolic syndrome. Candidates must meet the following criteria: waist circumference exceeding 40 inches (men) or 35 inches (women); fasting triglycerides higher than 150 mg/dL; HDL cholesterol lower than 40 mg/ dL for males and 50 mg/dL for females; systolic blood pressure over 130 mmHg and diastolic above 85 mmHg; glucose levels greater than 100mg/dL when not eating; BMI of 30 or more."

Answered by AI